4 Red Flags in HealthTech Startup Pitch Decks Investors Miss
HealthTech (Health Technology) startups have sector-specific risk patterns that general-purpose due diligence frameworks miss. These 4 red flags are the ones experienced HealthTech investors have learned to detect — often the hard way.
DDR automatically detects all 4 of these flags when you upload a HealthTech startup pitch deck. See a sample report.
FDA clearance not secured for medical device or diagnostic claims
Any product that makes diagnostic or treatment claims requires FDA 510(k) clearance or De Novo authorization. Selling without clearance is illegal and investor-threatening.
No HIPAA Business Associate Agreement (BAA) template
Any company handling Protected Health Information (PHI) must execute BAAs with covered entities. Absence signals regulatory immaturity.
Clinical claims without peer-reviewed evidence
Healthtech companies that claim clinical superiority without published studies or rigorous data will face regulatory and payor scrutiny that stalls commercialization.
No payor reimbursement pathway defined
Without a CPT code or payor coverage policy, the product's commercialization depends entirely on out-of-pocket or employer-sponsored payment.
Positive Signals in HealthTech Pitch Decks
HealthTech Due Diligence — All Guides
Screen Any HealthTech Startup in 5 Minutes
Upload a pitch deck PDF and DDR automatically runs this full due diligence framework — 13 OSINT sources, founder verification, all sector-specific red flags, comparable company analysis, and INVEST/PASS verdict.
GET YOUR FREE SCAN →